Correlation of Blood Pressure with Serum Magnesium Levels during Treatment of Preeclampsia with Magnesium Sulphate: A Cross Sectional Study
Journal Title: IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) - Year 2018, Vol 17, Issue 12
Abstract
Magnesium sulphate is effective in the prevention and treatment of seizures of preeclampsia. Although postulated to have antihypertensive effects; its use as an antihypertensive in preeclampsia management is however yet to be established. Our study aimed to determine the relationship between serum magnesium and blood pressure levels during treatment of preeclampsia with magnesium sulphate. It is a secondary analysis of data obtained from a prospective cross sectional study, on the clinical and biochemical correlates of preeclampsia among 75 patients who were administered magnesium sulphate (MgS04) using the Pritchard protocol. The results of serum magnesium assay obtained before each dose of MgS04, were correlated with the mean arterial blood pressure (MABP), using Pearson correlation statistics. The participants were mostly admitted in the antepartum period 67/75 (89.3%), with mean gestational age of 36.4±3.0 weeks. The mean loading dose (LD)-delivery interval was 5.94±4.2hrs. Significant proteinuria was predictive of severe hypertension (95%CI 0.003-0.006, p=0.005) while significantly lower rates of severe hypertension occurred among patients who had convulsed before admission (95%CI 0.073-0.564, p=0.002, OR=0.203). No significant correlation was found between MABP and serum magnesium level before (r=0.223, p=0.054) and during treatment with magnesium sulphate [4hrs (r=0.120, p=0.321), 8hrs (r=0.064, p=0.602), 12hrs (r=0.078, p=0.526), 16hrs (r=-0.026, p=0.834), 20hrs (r=-0.027, p=0.833), 24hrs (r=-0.151, p=0.238)] respectively. Also, severe hypertension (MABP≥125mmHg) had no statistically significant relationship with serum magnesium levels throughout treatment; 4hrs (p=0.462), 8hrs (p=0.208), 12hrs (p=0.346), 16hrs (p=0.925), 20hrs (p=0.376) and 24hrs (p=0.887) respectively. While MABP demonstrated a progressive decline in slope until completion, serum magnesium levels had a sinusoidal pattern with a peak at 8hrs. The MABP was not significantly affected by magnesium sulphate administered for seizure treatment. Thus, antihypertensive drugs should be administered for blood pressure control during treatment of preeclampsia with magnesium sulphate.
Authors and Affiliations
John Osaigbovoh IMARALU, OlabisiMorebise LOTO, Franklin Inyang ANI, Isaac ADEDIJI, Abimbola AFOLABI- IMARALU
Keywords
Related Articles
- EP ID EP421598
- DOI 10.9790/0853-1712022432.
- Views 64
- Downloads 0
Osteosarcoma: Current treatment trends and outcome
Osteosarcoma is more common in pediatric patients and in males In the US. there is ethic variation more common in individuals of black than white. Frequent causes includes: familial cases, bone dysplasia,fraumeni syndrom...
Tooth Agenesis; Aetiological Factors Abdulgani
Tooth agenesis is the most prevalent craniofacial congenital anomaly in humans. The term refers to an isolated disorder in the absence of non-dental phenotypes but is also used to describe the manifestation of missing te...
Case Control Study of Serum Vitamin D Levels in PCOS Patients
.
Assessment of sCD36 levels and Lipids in Type II Diabetes Mellitus
Background: Cluster determinant 36 (CD36) is a fatty acid translocase which is expressed in variety of cells. Increased expression of CD36 is observed in liver, adipose tissue and skeletal muscle. Non-cell bound CD36 was...
Attenuating the Haemodynamic Stress To Laryngoscopy And Intubation With I.V. Magnesium Sulphate And LignocaineComparative Study
Direct laryngoscopy and endotracheal intubation frequently induces a cardiovascular stress response characterized by hypertension and tachycardia due to reflex sympathetic simulation. The response is transient occurring...